|
Dmitrieva D.S., Filatova D.A., Pavlikova E.P., Krasnova T.N., Mershina E.A., Lisitskaya M.V., Trukhanova M.A., Seredenina E.M., Vaipan D.V., Polyakov R.S., Vartanyan E.L., Sinitsyn V.E.
Role of computed tomographic dynamic myocardial perfusion in the diagnosis of functional significance of coronary artery stenosis
|
№6 / 2024
|
|
Magamadov I.S., Skorodumova E.A., Kostenko V.A., Pivovarova L.P., Ariskina O.B., Siverina A.V., Skorodumova E.G.
Association of I/D polymorphism of ACE gene with different course of chronic heart failure and myocardial remodeling in patients with coronary heart disease after coronary artery bypass grafting
|
№6 / 2024
|
|
Sergeeva O.S., Salamatova V.N., Kotova Yu.A., Shevtsov A.N., Shevtsova V.I.
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease
|
№6 / 2024
|
|
Kobzeva N.D., Shlyk S.V., Amarna S.S., Oleynikova V.D.
Clinical case of orthotopic cardiac transplantation with further acute humoral rejection of the graft
|
№4 / 2024
|
|
Gridneva Yu.Yu., Chesnikova A.I., Safronenko V.A., Edlenko E.V., Zatloukal M.Yu.
Incidence degree and clinical significance of first detected hypothyroidia in patients with ST-segment elevation myocardial infarction
|
№4 / 2024
|
|
Davydova N.A., Lebedev P.A., Chernyshev A.V., Kornilin D.V., Grishanov V.N., Komarova M.V.
Clinical and prognostic value of the skin autofluorescence parameter in coronary heart disease and peripheral arterial disease patients
|
№2 / 2024
|
|
Rogozhkina E.A., Ivanova A.A., Novikov M.Y., Drogashevskaya N.V., Samatova K.S., Bogodistaya V.V.
Antithrombotic therapy in patients with diabetes mellitus
|
№8 / 2023
|
|
Alieva A.M., Teplova N.V., Butenko A.V., Averin E.E., Akhmedova M.F., Shikhova Yu.A., Valiev R.K., Saryev M.N., Kotikova I.A., Nikitin I.G.
MicroRNA-1 and microRNA-133: Small moleculesof great importance in the aspect of cardiovascular diseases
|
№2 / 2023
|
|
Roytberg G.E., Slastnikova I.D., Sharkhun O.O., Davydova A.S.
Value of cardiovascular risk factors in pre-test assessment of coronary heart disease
|
№1 / 2023
|
|
Suvorova N.A., Gordeev I.G., Luchinkina E.E.
Osteopontin in chronic obstructive pulmonary disease patients as a predictor of cardiovascular events
|
№9 / 2022
|
|
Budnevsky A.V., Ovsyannikov E.S., Nekhaenko N.E., Ostroushko N.I., Simion A.Yu., Martynov A.I.
Influence of anemic syndrome correction on the course of coronary heart disease in outpatient practice
|
№8 / 2022
|
|
Alieva A.M., Teplova N.V., Ettinger O.A., Reznik E.V., Baykova I.E., Sarakaeva L.R., Shnahova L.M., Arakelyan R.A., Valiev R.K., Nikitin I.G.
The role of interleukin 12 in the development of cardiovascular diseases
|
№6 / 2022
|
Русский
